Market Outlook
- In 2026, the market in South Korea is estimated to stand at USD 1.14 Billion.
- As per our research, the South Korea Infusion Services Market to reach USD 2.88 Billion by 2034, with a forecasted CAGR of 12.30% across the projection period.
NHI Reimbursement Caps: Outpatient Infusion Volume Shifts
What the surface data understates is how South Korea's National Health Insurance reimbursement schedule — which sets inpatient infusion administration fees at rates that compress provider margins on biologic and specialty infusion protocols — is materially redirecting infusion volume toward ambulatory and home-based settings where per-visit reimbursement structures are comparatively more favourable. Specialty infusion service providers operating outside acute hospital settings face a structural opening: NHI's tiered reimbursement model creates a cost-efficiency incentive for payers and referring clinicians to route eligible patients toward lower-acuity infusion environments, generating demand for clinically credentialed outpatient and home infusion service operators. Providers capable of meeting NHI accreditation standards for non-hospital infusion delivery, while maintaining the clinical monitoring protocols required for biologic therapies, are positioned to absorb volume that hospital-based infusion units are increasingly unable to serve profitably under current fee schedules.
Market Scope
Table of Contents
Paid Customization
Tailor This Report to Your Exact Needs
All customization options are available on request. Our team will scope your requirements and provide a proposal within 48 hours.
Request a Free Sample
- Executive Summary & Strategic Market Overview
- Key market sizing metrics with CAGR projections
- Representative data tables, charts & segment breakdowns
- Competitive landscape preview with leading player profiles
- Methodology note and data validation framework
- Delivered to your corporate inbox within 24 business hours
- Available in PDF format — no login or download barrier
- Accompanied by a dedicated research analyst introduction
- Option to schedule a complimentary 15-minute briefing call
- SSL-encrypted submission — your data is transmitted securely
- GDPR-compliant data handling — zero third-party sharing
- Trusted by 500+ Fortune 1000 companies & government bodies
- ISO-aligned research processes with independent data validation
No commitment required. No credit card. Delivered within 24 business hours.